---
document_datetime: 2025-11-24 16:45:58
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cetrotide-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: cetrotide-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 16.7321406
conversion_datetime: 2025-12-19 00:38:29.61254
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Cetrotide

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 24/11/2025                          |                                          | Labelling and                   |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | Update of the Labelling to align instruction forUse(IFU)concerning the injection angle andsite.The updateprovides clearer guidance on the recommended injection site inthelower abdominalareaandon maintaining an appropriate distance from the navel, as well as specifying a preferred injection angle to support correct subcutaneous administration.The MAH is also taking theopportunitytointroduce some minor editorial changes to the labelling and package leaflet.                                                                                               |            |     | PL   | EMA/N/0000308409   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|--------------------|
| Variation type IB / EMA/VR/0000307159 | This was an application for a group of variations. B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in themanufacturingprocessof theactive substance orchangeinthemanufacturer (including where relevant quality control testing sites)ofthe active substance,where noPh.Eur.Certificate of Suitability is part of the approved dossier -B.I.a.1.z Other variation - Accepted B.I.d.1.a Re-test period/storage period - B.I.d.1.a.4 Extension orintroduction of a re- test period/storage period supported by real time data- Accepted | 10/11/2025 | N/A |      |                    |

<div style=\"page-break-after: always\"></div>